{"id":"W4390618444","doi":"10.1007/s40261-023-01329-9","title":"Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches","year":2024,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Imatinib; Health care; Tyrosine kinase; Tyrosine-kinase inhibitor; Life expectancy; Intensive care medicine; Tolerability; Pharmacology; Cancer research; Internal medicine; Cancer; Environmental health; Population; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001634756,0.0003613638,0.001082544,0.0002149029,0.000114608,0.00004493678,0.0001591612,0.0002659499,0.000001463815],"category_scores_gemma":[0.0001971601,0.0001938514,0.0001258942,0.0006626612,0.001472025,0.00009862077,0.0001280185,0.0005311622,5.090293e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009775814,"about_ca_system_score_gemma":0.001553047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005104918,"about_ca_topic_score_gemma":0.0001497184,"domain_scores_codex":[0.9963067,0.0009852182,0.00145585,0.0005873209,0.0004486496,0.000216328],"domain_scores_gemma":[0.9980785,0.0003671593,0.0009642061,0.0004200576,0.00007380047,0.00009631704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001510551,0.0001536714,0.004734286,0.06490123,0.0003762654,0.0001041416,0.000911693,0.00210678,0.000007843468,0.0009722661,0.00004061074,0.9255401],"study_design_scores_gemma":[0.01465056,0.003950984,0.01007035,0.4931974,0.0323887,0.001836086,0.005109219,0.4215093,0.0007512737,0.0007270194,0.01376517,0.002043929],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1069696,0.8878788,0.0001522732,0.0004990223,0.0001187222,0.004305242,0.00002856572,0.0000201097,0.00002769985],"genre_scores_gemma":[0.09940933,0.8969322,0.003013861,0.00007349889,0.0001500635,0.00008606993,0.0002545657,0.00005468498,0.00002570284],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9234962,"threshold_uncertainty_score":0.790503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1519643380121963,"score_gpt":0.3743277414487546,"score_spread":0.2223634034365582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}